This application is the resubmission for the competing continuation of a program project grant that was initiated in 1986. The proposed research is the outgrowth of the program's progress during the current funding period, and consists of three projects and two supporting cores, focused on the central theme of digitalis-induced signaling through the cardiac Na*7K+-ATPase. The participating investigators with expertise in membrane biochemistry, protein chemistry, molecular genetics, cell biology, and integrative cardiovascular physiology/ pharmacology will combine their efforts to conduct the following studies: Project I attempts to determine the molecular and cellular mechanisms by which the digitalis-induced activation of class 1A PI3K/Akt pathway leads to cardiac myocyte hypertrophy, and to assess if this seemingly benign hypertrophy is capable of antagonizing the deleterious effects of pathological hypertrophy and its consequences. Project 11 concentrates on the unraveling of the molecular interactions that constitute the formation of the Na+/K+- ATPase/Src complex, and on the evaluation of this complex as the receptor for the initiation of the multiple digitalis-induced signaling pathways and their functional consequences in the heart. Project III focuses on the established digitalis-induced communication between cardiac sarcolemmal Na+/K+-ATPase and ATPsensitive K+ channels of cardiac mitochondria, and proposes to determine the molecular and subcellular mechanisms of this communication, and the resulting digitalis-induced protection of the heart against ischemia-reperfusion injury. The core units are designed to provide administrative support and efficient management of the experimental animals and other shared resources of the program. These proposed studies are expected to expand knowledge on the newly appreciated physiological roles of cardiac NaVK4- ATPase, and to provide the bases for novel approaches to the prevention and treatment of ischemic heart disease and heart failure.

Public Health Relevance

Digitalis is the oldest of the drugs that are commonly used to treat heart failure patients with limited success. We propose the continuation of our recent research that has revealed previously unrecognized effects of digitalis on the heart cells, and suggests that if this inexpensive and readily available drug is used in new ways, it may become a safe, effective, and world-wide treatment for heart failure and for prevention of heart attacks.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Program Projects (P01)
Project #
Application #
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Program Officer
Adhikari, Bishow B
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Toledo
Schools of Medicine
United States
Zip Code
Alshahrani, Musaed M; Yang, Eunice; Yip, Jana et al. (2014) CEACAM2 negatively regulates hemi (ITAM-bearing) GPVI and CLEC-2 pathways and thrombus growth in vitro and in vivo. Blood 124:2431-41
Najjar, Sonia M; Russo, Lucia (2014) CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH). Semin Immunopathol 36:55-71
Gable, Marjorie E; Abdallah, Simon L; Najjar, Sonia M et al. (2014) Digitalis-induced cell signaling by the sodium pump: on the relation of Src to Na(+)/K(+)-ATPase. Biochem Biophys Res Commun 446:1151-4
Li, Daxiang; Wu, Jian; Bai, Yan et al. (2014) Isolation and culture of adult mouse cardiomyocytes for cell signaling and in vitro cardiac hypertrophy. J Vis Exp :
Ye, Qiqi; Lai, Fangfang; Banerjee, Moumita et al. (2013) Expression of mutant ýý1 Na/K-ATPase defective in conformational transition attenuates Src-mediated signal transduction. J Biol Chem 288:5803-14
Bai, Yan; Morgan, Eric E; Giovannucci, David R et al. (2013) Different roles of the cardiac Na+/Ca2+-exchanger in ouabain-induced inotropy, cell signaling, and hypertrophy. Am J Physiol Heart Circ Physiol 304:H427-35
Belliard, Aude; Sottejeau, Yoann; Duan, Qiming et al. (2013) Modulation of cardiac Na+,K+-ATPase cell surface abundance by simulated ischemia-reperfusion and ouabain preconditioning. Am J Physiol Heart Circ Physiol 304:H94-103
Najjar, Sonia M; Ledford, Kelly J; Abdallah, Simon L et al. (2013) Ceacam1 deletion causes vascular alterations in large vessels. Am J Physiol Endocrinol Metab 305:E519-29
Garlid, Keith D; Halestrap, Andrew P (2012) The mitochondrial K(ATP) channel--fact or fiction? J Mol Cell Cardiol 52:578-83
Liu, Changxuan; Bai, Yan; Chen, Yiliang et al. (2012) Reduction of Na/K-ATPase potentiates marinobufagenin-induced cardiac dysfunction and myocyte apoptosis. J Biol Chem 287:16390-8

Showing the most recent 10 out of 233 publications